Nuvectis Pharma Inc
NVCT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$603.26M
Close$
$1.45
92.4% downside
Current Fair Value
92.4% downsideOvervalued by 92.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $603.26 Million |
|---|---|
| Enterprise Value | $582.49 Million |
| Earnings per Share | $-1.32 |
| Beta | -0.24 |
| Outstanding Shares | 23,475,989 |
Return
| Return on Equity | -333.35% |
|---|---|
| Return on Assets | -135.30% |
| Return on Invested Capital | -20.78% |
Valuation & Multiples
| P/E Ratio | -14.11 |
|---|---|
| PEG | -130.25 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -308.69 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.29
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.22
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 16.79% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.60%▼ 43.28% |
|---|---|
| Total Invested | $2.96M▼ 98.44% |
| Investors Holding | 8▼ 85.00% |